IPO alert: Windlas Biotech files draft papers for IPO
Representational image/IPO
Windlas Biotech Ltd has filed preliminary papers with markets regulator Sebi for an initial public offer that includes a fresh issue of Rs 165 crore.
Besides the fresh issue, there will be an offer for sale of shares. The company is into domestic pharmaceutical formulations contract development and manufacturing business.
According to the Draft Red Herring Prospectus (DRHP), the company will also consider a pre-IPO (Initial Public Offer) placement of up to Rs 50 crore.
The proposed offer includes fresh issue of Rs 165 crore and an offer for sale of up to 5,142,067 equity shares. The latter will comprise up to 1,136,000 equity shares by the individual selling shareholder and up to 4,006,067 equity shares by the investor selling shareholder , as per the document.
streetAsia s premium subscription service Unlock your competitive advantage in a rapidly evolving landscape. Our packages come with exclusive access to archive content, data, discount on summit tickets & more. Be a part of our growing community now. SUBSCRIBE NOW
Singapore Reporter/s
In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digi